Circulation

DECEMBER 3, 2024

Circulation, Ahead of Print. Smokeless oral nicotine products are addictive, and their use has potential adverse effects on some but not all biomarkers of cardiovascular risk. Similarly, smokeless tobacco has the potential to increase the risk of oral cancer, but the risks depend on the chemical composition of the product.

Cardiovascular Disease 73

Cardiovascular Disease Cerebrovascular Disease Pharmacology Biomarkers 73

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2024

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block immune checkpoints and therefore activate immune cells, allowing them to recognize and attack cancer cells. ICIs have revolutionized oncology practice, but their use has been complicated by immune-related adverse events (irAEs).

Biomarkers 64

Biomarkers Circulation Cancer Outcomes 64

Dr. Paddy Barrett

FEBRUARY 21, 2025

These stages can range from mild fatty liver infiltration to serious scarring and fibrosis terminating in liver cirrhosis and potentially liver cancer. Type 2 Diabetes When it comes to the increasing the risk of major chronic diseases such as cardiovascular disease, many cancers and dementia, type 2 diabetes plays a huge role.

Obesity 77

Obesity Diabetes Cardiovascular Disease Chronic Disease 77

Circulation: Cardiovascular Quality & Outcomes

SEPTEMBER 2, 2024

Circulation: Cardiovascular Quality and Outcomes, Volume 18, Issue 1 , Page e011504, January 1, 2025. BACKGROUND:Risk stratification strategies for cancer therapeuticsrelated cardiac dysfunction (CTRCD) rely on serial monitoring by specialized imaging, limiting their scalability. to 15% [interquartile range, 15% to 9%] for 0.5 [P<0.001]).CONCLUSIONS:AI

Cancer 40

Cancer Cardiomyopathy Echocardiogram Biomarkers 40

Circulation: Genomic and Precision Medicine

FEBRUARY 24, 2025

Circulation: Genomic and Precision Medicine, Ahead of Print. Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease and its treatments.

Cardio Oncology 40

Cardio Oncology Cancer Biomarkers Cardiovascular Disease 40

Dr. Paddy Barrett

SEPTEMBER 13, 2024

Understanding where you sit on this continuum is a key part of defining your future risk of heart disease but also dementia, and many cancers. The further along the line of insulin resistance you sit, the higher your risk of all the leading causes of death, including heart disease, dementia and many cancers 5. Circulation.

Risk Factors 105

Risk Factors Heart Disease Dementia Diabetes 105

DAIC

MAY 8, 2024

The study was published today in Circulation Research , an American Heart Association journal, with Stefanos Zafeiropoulos, MD PhD , as the lead author and Stavros Zanos, MD PhD , as the senior author. This was done in preclinical models, but could apply to humans for whom PAH is rare but fatal and affects predominantly younger women.

Ultrasound 115

Ultrasound Pulmonary Research Hypertension 115